Skip to main content
Clinical Trials/ACTRN12619000006145
ACTRN12619000006145
Recruiting
N/A

Algorithm feasibility of a novel oxygen delivery system using comfort mode and closed-loop oxygen control in participants with chronic lung disease

Fisher and Paykel0 sites8 target enrollmentJanuary 8, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD
Sponsor
Fisher and Paykel
Enrollment
8
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2019
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fisher and Paykel

Eligibility Criteria

Inclusion Criteria

  • 1\. Doctor’s diagnosis of a chronic respiratory disease such as COPD, bronchiectasis and Interstitial Lung Disease
  • 2\. Stable respiratory state with no exacerbation in last 4 weeks
  • 1\. Doctor’s diagnosis of a chronic respiratory disease such as COPD, bronchiectasis and Interstitial Lung Disease
  • 2\. Prescribed long term oxygen therapy (LTOT) for use at rest
  • 3\. Stable respiratory state with no exacerbation in last 4 weeks
  • 4\. Hypercapnic (PtCO2 \>45mmHg), with SpO2 \<88% at rest breathing room air OR Normocapnic (PtCO2 less than or equal to 45mmHg), with SpO2\<92% at rest breathing room air

Exclusion Criteria

  • Group A and B
  • 1\. Age \<18
  • 2\. Cognitive impairment
  • 3\. Diagnosis of a notifiable disease (eg. hepatitis, TB, rheumatic fever, HIV, gastroenteritis)
  • 4\. The presence of an implantable Medical Device (eg. pacemaker, defibrillator, neurostimulator or insulin pump)
  • 5\. Known infection or colonization with multidrug resistant bacteria, Pseudomonas species, Burkholderia Cepacia or mycobacteria
  • 6\. The presence of an implantable Medical Device (eg. Pacemaker, defibrillator, neurostimulator, or insulin pump).
  • 7\. Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.
  • Group B ONLY
  • 1\. Inability to tolerate an interruption in oxygen therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials